PlantX - Trend Seeker® BUY 20 Day Moving Average BUY
PlantX - Trend Seeker® BUY 20 Day Moving Average BUY (CAD/USD)
20 - 50 Day MACD Oscillator
BUY
20 - 100 Day MACD Oscillator
BUY
20 - 200 Day MACD Oscillator
BUY
20 - Day Average Volume: 166,405 Average: 100% BUY
Medium Term Indicators
50 Day Moving Average
BUY
50 - 100 Day MACD Oscillator
BUY
50 - 150 Day MACD Oscillator
BUY
50 - 200 Day MACD Oscillator
BUY
50 - Day Average Volume: 159,195 Average: 100% BUY
Long Term Indicators
100 Day Moving Average
BUY
150 Day Moving Average
BUY
200 Day Moving Average
BUY
100 - 200 Day MACD Oscillator
SELL
100 - Day Average Volume: 146,588 Average: 50% BUY
Source; barchart.com
1
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Festive Foil for Holiday Creativity Well, just like that, Reynolds Wrap® is sprinkling some holiday magic into kitchens across the country. They're rolling out this limited-edition Snowflakes Fun Foil®, and it's not just aluminum with a pretty design—it's a tool for all those holiday-driven projects and gatherings. It's that time of year when the air hums with the...
Continue Reading
Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...
Continue Reading
A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...
Continue Reading
Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...
Continue Reading
Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...
Continue Reading
Stockholders Left Scrambling You ever have one of those days where everything is cruising along, then bam—you hit what feels like a pothole the size of Texas? Well, that's NPK International (NYSE: NPKI) right now. Their recent revenue cut sent shareholders spiraling, and now there's a legal storm brewing, led by Levi & Korsinsky. Weather Woes Lead to Lower Earnings So,...
Continue Reading
APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...
Continue Reading
MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...
Continue Reading
Revolutionizing Government Tech with AI Springbrook Software is positioning itself as a frontrunner in modernizing government tech, unveiling a suite of AI-driven innovations under its Cirrus ERP platform. During their recent conference, Activate 2026, held in Orlando, the commitment to transforming how local governments operate was clear. With new tools like AI Invoicing...
Continue Reading
Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...
Continue Reading
Top 5 Most Recently Viewed Articles
Sana Biotechnology Schedules Key Investor Presentations SEATTLE — Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering company committed to transforming patient care through engineered cells, has exciting news for its stakeholders. The company announced its participation in several notable investor conferences this coming September. This series of presentations will...
Continue Reading
GAC and Magna Team Up for Electric Mobility Growth In an exciting development for the electric vehicle (EV) industry, GAC and Magna have announced a new vehicle assembly program aimed at accelerating electric mobility and bolstering localized EV production in Europe. This collaboration is a testament to GAC’s commitment to expanding its presence in the European market...
Continue Reading
Meriaura Group Financial Overview Meriaura Group Plc announced critical details in their financial release showcasing the company's financial performance from January to December 2024. This unique insight highlights the adjustments in revenue from two significant business segments: Marine Logistics and Renewable Energy. During the fourth quarter, Meriaura experienced a...
Continue Reading
Brillio Earns Esteemed Recognition in Life Sciences Services Brillio, known as The Enterprise AI Accelerator, has recently achieved significant recognition in the HFS Horizons: Life Sciences Service Providers 2025 report. This honor reflects Brillio's commitment to leveraging AI-driven innovation to deliver impactful health outcomes, enhance patient experience, lower...
Continue Reading
Vital Information for Altimmune Investors Altimmune, Inc. (NASDAQ: ALT) shareholders are encouraged to stay informed about their rights and the ongoing class action considerations that may affect their investments. There's an upcoming deadline for shareholders to register for potential recovery in light of recent events that significantly impacted the stock value....
Continue Reading